Honorary Degree Recipient and Keynote Speaker
Rutgers Law School
Anita Hill, Professor, Brandeis University
Camden College of Arts and Sciences & University College
Dana Redd, SBC’96, Chief Executive Officer, Rowan University/Rutgers–Camden Board Governors
Sandy J. Stewart, CCAS’81, GSC’87, Co-Founder and CEO (retired), Paradigm Genetics (now Cogenics Icoria, Inc.)
School of Business–Camden
Stephen A. Tullman, SBC’89, Co-Founder and Managing Partner, NeXeption, LLC
School of Nursing–Camden
Linda J. Stierle, Brigadier General (retired), U.S. Air Force, and Chief Executive Officer (retired), American Nurses Association
Professor, Brandeis University
She is a prolific author, commentator, and scholar whose perspectives have contributed to the national dialogue about equitable treatment in the workplace and in society for more than 25 years.
She graduated from Yale Law School in 1980 and began her career in private practice in Washington, D.C. She then accepted a position working for the Honorable Clarence Thomas at the U.S. Department of Education's Office of Civil Rights and, later, the Equal Employment Opportunity Commission.
Her career and life serve as a living testament to her commitment to equity for all Americans, particularly regarding the importance of equal rights for women. Hill’s 1991 testimony before the U.S. Senate Judiciary Committee during Thomas’ confirmation hearings for his appointment to the U.S. Supreme Court ignited the national conversation about sexual harassment that continues to command attention. During the hearings, Hill alleged that Thomas had frequently taken inappropriate liberties in his interactions with her during her employment. Hill's testimony became the subject of national debate about sexual harassment and her experiences made her a symbol for conversations about workplace misconduct, inequality, and discrimination. Her courageous refusal to be silent and her steadfast commitment to fighting sexual harassment and gender-based discrimination have persisted for more than a quarter of a century.
Hill’s latest book is Reimagining Equality: Stories of Gender, Race, and Finding Home (Beacon Press, 2011). Time, Newsweek, The New York Times, The Boston Globe, and Ms. magazine have published her commentary, and she has made numerous appearances on national television.
In a 2017 New York Daily News article regarding allegations of sexual misconduct perpetrated by film producer Harvey Weinstein, Hill noted that “Despite a generation growing up hearing that sexual harassment is unacceptable, it clearly remains a plague.” In the wake of the surging national crisis regarding sexual harassment in late 2017, she took the lead in a campaign against sexual abuse in the media and entertainment industries by heading up the Commission on Sexual Harassment and Advancing Equality in the Workplace.
She is the recipient of many awards, grants, and honorary degrees. Hill’s professional and civic contributions include chairing the Human Rights Law Committee of the International Bar Association and membership on the Board of Governors of Tufts Medical Center, the Board of Directors of the National Women’s Law Center, and the Boston Area Lawyers Committee for Civil Rights. In 1989, she became the first African American to be tenured at the University of Oklahoma College of Law.
Hill received a bachelor’s degree from Oklahoma State University and a juris doctor from Yale University.
Chief Executive Officer, Rowan University/Rutgers–Camden Board Governors
In October 2017, the RURCBOG broke ground on the construction of a 95,000-square-foot Joint Health Sciences Center that will be located at Broadway and Stevens Street in Camden. The building will deliver education and training opportunities to a new generation of health care providers while also providing world-class research space for Rutgers, Rowan, and Camden County College faculty developing innovations in the biosciences and allied health.
Redd joined the RURCBOG after completing two terms as mayor of Camden. A proven and experienced leader with over 20 years of service in the public sector, Redd successfully transitioned the city from state takeover to local control. Among her accomplishments is the first investment grade rating the city had received in more than 15 years.
In 2014, Standard & Poor’s Rating Services (S&P) published an issuer credit rating of BBB+. S&P recognized the fiscal controls the Redd administration instituted in order to improve and stabilize the finances of the city.
During her time as mayor, Redd led a full state intervention for the public school system to improve academic outcomes for urban youth. The state and local partnership focused on creating the “cradle to college to career” pipeline in education offered through traditional, charter, and Renaissance schools.
As a state senator, Redd served on the Budget Appropriations Committee, the Joint Committee on Public Schools, and the Urban Affairs Committee. She sponsored and negotiated the passage of legislation creating the Homeless Trust Fund and $3.9 billion in new school construction funding for New Jersey Abbott Districts.
She earned her bachelor’s degree from the Rutgers School of Business–Camden and her master's degree in human services administration from Lincoln University. Redd has received numerous honors, including the Extraordinary Leadership Award from Campbell Soup Company and induction into the alumni hall of fame at Rutgers University–Camden. She served as the 2017 commencement speaker for Camden County College.
In addition to her business acumen and volunteerism, Redd fosters and values the importance of civic engagement, grassroots organizing and responsible redevelopment. She is a motivational speaker for interfaith organizations, professional women’s groups and chambers of commerce.
Co-Founder and CEO (retired), Paradigm Genetics (now Cogenics Icoria, Inc.)
Sandy Stewart is a highly respected biotech industry entrepreneur and scientist. Now retired, Stewart co-founded several biotechnology companies including Immunovation and Paradigm Genetics (now Cogenics Icoria, Inc.). These companies spanned functional genomics, proteomics, and immunology into drug development and diagnostics. More recently, he joined Metabolon, the world’s leader in metabolomics, to advance technology that he developed in 1998. He was one of the first in the world to greatly advance the technology of biochemical profiling allowing ultra-high throughput analysis and subsequently creating a new field of science called metabolomics. He began his biotech career at the pharmaceutical company Novartis in Research Triangle Park, N.C. He is well-published and holds numerous patents.
During his career, Stewart has also worked with the American Red Cross and the United Nations on HIV and Prionics AG on bovine spongiform encephalitis, more commonly known as “mad cow disease.”
Among his many awards and honors are the 1995 Ciba AgriNova International Award and President’s Council Award, the 1998 Center for Entrepreneurial Development Start-up of the Year, and 2000 runner-up to Ernst and Young’s Entrepreneur of the Year.
Stewart is the chair of the Rutgers Board of Governors and is the first Rutgers University–Camden graduate to lead the University’s governing body. He is the former chair of the Rutgers Board of Trustees, to which he was first appointed in 2006. Stewart has served on most Board of Trustees and Board of Governors committees over the years, including the Board of Trustees Joint Investments Committee, the Governance Improvement Task Force, the Rutgers–Camden Alumni Association Board, and the Rutgers University–Camden Board of Directors.
Stewart was inducted onto the Rutgers Board of Governors in July 2015. When he was inducted onto the Board of Governors, Rutgers President Robert Barchi praised Stewart, saying: “We are delighted that Mr. Stewart will continue his distinguished service at Rutgers as a member of the Board of Governors. We especially look forward to capitalizing on his expertise in the field of biotechnology, which is a vital contributor to the health of the state’s economy.”
Brigadier General (retired), U.S. Air Force, and Chief Executive Officer (retired), American Nurses Association
A national leader in nursing and health care, Brigadier General Linda J. Stierle retired from a distinguished career of military service in 2000 after serving as the twelfth Chief of the Nurse Corps and director of medical readiness and nursing services for the Office of the Air Force Surgeon General at Bolling Air Force Base in Washington, D.C. In these roles, she shared responsibilities for the development of health care policy in support of 46,000 medical personnel and 80 medical treatment facilities, as well as oversight of a $4.5 billion budget. She developed policies affecting 19,000 nursing personnel in active and reserve components and was responsible for training, organizing, and equipping all Air Force medics.
Throughout her military career, Stierle earned some of the nation’s highest honors, including the Legion of Merit award with oak leaf cluster and the Meritorious Service Medal with three oak leaf clusters.
Upon retiring from military service, the brigadier general served as chief executive officer of the American Nurses Association, which is one of America’s largest and oldest professional nurses associations. In this role, she developed and implemented programs designed to meet the vision and goals of the association and leading and managing the association’s national headquarters, its operations, and its staff of nearly 200 individuals. She also served as CEO of the American Nurses Foundation. She retired from the American Nurses Association in 2009.
She was instrumental in the creation of ANA’s newest constituency for nurses in the uniformed services, the Federal Nurses Association (FedNA). In 2000, the ANA board of directors accepted FedNA as the 54th constituent member.
In 2002, President George W. Bush appointed Stierle to a five-year term on the Board of Regents of the Uniformed Services University of the Health Sciences where she served as vice chair of the board. She is also a member of the consumer advisory board of the American Academy of Family Physicians, as well as the Tau Theta Chapter of Sigma Theta Tau International, the American Organization of Nurse Executives, the Society of Air Force Nurses, and the American Society of Association Executives.
Stierle earned her bachelor’s degree in nursing from Incarnate Word College and her master’s degree in nursing from the University of California, San Francisco.
Co-Founder and Managing Partner, NeXeption, LLC
Stephen Tullman’s career spans more than 25 years of biopharmaceutical global commercialization and drug development experience. He serves as the co-founder and managing partner for NeXeption, LLC, and co-founder and chair of Aclaris Therapeutics.
He was chair and CEO of Ceptaris Therapeutics (acquired by Actelion in 2013); co-founder and chair of Vicept Therapeutics (acquired by Allergan in 2011); co-founder, president, and CEO of Ception Therapeutics (acquired by Cephalon in 2010); and co-founder of Trigenesis Therapeutics, a dermatology company (acquired by Reddy's Laboratories in 2004).
He also served on the Board of Directors for Euromed, a wound care company. Tullman started his career at SmithKline Beecham and held positions of increasing responsibility in finance, sales, marketing, and research and development.